相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of Tmprss6-ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
Carla Casu et al.
HAEMATOLOGICA (2016)
Combination of Tmprss6-ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
Carla Casu et al.
HAEMATOLOGICA (2016)
siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
Shigeo Matsuda et al.
ACS CHEMICAL BIOLOGY (2015)
Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia
Paul J. Schmidt et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Macrophages and iron trafficking at the birth and death of red cells
Tamara Korolnek et al.
BLOOD (2015)
Hepatocyte-Specific Delivery of siRNAs Conjugated to Novel Non-nucleosidic Trivalent N-Acetylgalactosamine Elicits Robust Gene Silencing in Vivo
Kallanthottathil G. Rajeev et al.
CHEMBIOCHEM (2015)
β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies
Stefano Rivella
HAEMATOLOGICA (2015)
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
Alfica Sehgal et al.
NATURE MEDICINE (2015)
β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies
Stefano Rivella
HAEMATOLOGICA (2015)
Modulation of Hepcidin as Therapy for Primary and Secondary Iron Overload Disorders Preclinical Models and Approaches
Paul J. Schmidt et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Updates of the HbVar database of human hemoglobin variants and thalassemia mutations
Belinda Giardine et al.
NUCLEIC ACIDS RESEARCH (2014)
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/- mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia
Paul J. Schmidt et al.
BLOOD (2013)
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
Shuling Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Antonella Nai et al.
BLOOD (2012)
Contemporary approaches to treatment of beta-thalassemia intermedia
Ali T. Taher et al.
BLOOD REVIEWS (2012)
siRNA-optimized Modifications for Enhanced In Vivo Activity
Denise M. Kenski et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism
Yelena Ginzburg et al.
BLOOD (2011)
Complications and treatment of patients with β-thalassemia in France: results of the National Registry
Isabelle Thuret et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis
Alicia R. Folgueras et al.
BLOOD (2008)
The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane Hemojuvelin
Laura Silvestri et al.
CELL METABOLISM (2008)
A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron
Maria Antonietta Melis et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Karin E. Finberg et al.
NATURE GENETICS (2008)
The serine protease TMPRSS6 is required to sense iron deficiency
Xin Du et al.
SCIENCE (2008)
Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin
Sara Gardenghi et al.
BLOOD (2007)
Liver iron concentrations and urinary hepcidin in β-thalassemia
Raffaella Origa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
mRNA expression of iron regulatory genes in β-thalassemia intermedia and β-thalassemia major mouse models
Orly Weizer-Stern et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Thalassemia intermedia: Revisited
Ali Taher et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Decreased hepcidin mRNA expression in thalassemic mice
K Adamsky et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
分享论文
